A new report from cannabis delivery company Eaze highlights the challenges the legal market in California faces due to illicit sales.

The report claims that although 84 percent of California residents are satisfied with the legal market, one in five Californians has purchased a product from the black market in the past three months.


“A significant portion of California consumers who still purchase cannabis from unlicensed sources are satisfied with those sources, and are not incentivized to change,” the report says.

The study was done via an online poll of California and Colorado residents 21 years and older who had consumed cannabis in the past 30 days. Additional data was added from Eaze users.

In May, the California Department of Tax and Fee Administration (CDTFA) revealed the state had raked in US$60.9 million in tax revenue for sales in Q1 2018. Sales tax represented US$27.3 million of the total.

California legalized recreational cannabis this year, with sales starting on January 1.

After the release of results from the CDTFA, the Legislative Analyst’s Office for the state reduced its projections on tax revenue from an initial US$175 million for the entire year.

Consumers in California, according to Eaze, still face roadblocks when purchasing recreational cannabis. The three main complaints from consumers are taxes being too high, no electronic payment options and prices being too high.

In a San Francisco Business Times editorial it is estimated that consumers are paying as much as 45 percent in taxes when they buy recreational cannabis. As a result, some are buying from illicit venues.

“Simply stated, California has done a great job of telling consumers that cannabis is legal but has a long way to go in making it easy to get safe, legal and affordable cannabis,” the Eaze report states.

The company argues that since cannabis businesses operating illegally don’t have to face safety tests and other restrictions from the legal side, it gives them “strong market advantages.”

Eaze suggests that a 5-percent reduction of the overall tax rate in California could cause 23 percent of black market consumers to move into legal venues.

Despite the challenges California is facing when it comes to directing customers to legal options for cannabis consumption, one recent report still places it as one of the largest state markets in the US.

Data from New Frontier Data predicts that by 2020 California will be among the largest state markets for legal cannabis and will become the actual largest market for recreational use by 2025.

Investor takeaway

The promise of California being the biggest cannabis market available for investors took a hit with the tax revenue reduction from state officials. However, predictions still show the state as a prime market for adult-use cannabis.

Don’t forget to follow us @INN_Cannabis for real-time news updates! 

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less